Items where authors include "Metry, A."

Article

Metry, A., Pandor, A. orcid.org/0000-0003-2552-5260, Ren, S. et al. (5 more authors) (2023) Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis. Health Technology Assessment, 27 (14). ISSN 1366-5278

Rafia, R., Martyn-St James, M., Harnan, S. et al. (3 more authors) (2022) A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health, 25 (5). pp. 761-769. ISSN 1098-3015

Pennington, R., Alshreef, A., Flight, L. orcid.org/0000-0002-9569-8290 et al. (12 more authors) (2021) Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study. PharmacoEconomics, 39 (8). pp. 913-927. ISSN 1170-7690

Duarte, A., Walker, S., Metry, A. orcid.org/0000-0001-7412-6093 et al. (3 more authors) (2021) Jointly modelling economics and epidemiology to support public policy decisions for the COVID-19 response : a review of UK studies. PharmacoEconomics, 39 (8). pp. 879-887. ISSN 1170-7690

Hykin, P., Prevost, A.T., Sivaprasad, S. et al. (16 more authors) (2021) Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment, 25 (38). ISSN 1366-5278

Stevenson, M. orcid.org/0000-0002-3099-9877, Metry, A. orcid.org/0000-0001-7412-6093 and Messenger, M. (2021) Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis. Health Technology Assessment, 25 (39). ISSN 1366-5278

Stevenson, M., Metry, A. and Messenger, M. (2021) Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E : rapid cost-effectiveness analysis. Health Technology Assessment, 25 (21). pp. 1-68. ISSN 1366-5278

Proceedings Paper

Metry, A. orcid.org/0000-0001-7412-6093, Rafia, R. and Wailoo, A. orcid.org/0000-0002-9324-1617 (2022) EE315 Economic evaluation of neutralising monoclonal antibodies for the treatment of COVID-19 positive people in the community. In: Value in Health. ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington, DC, USA. Elsevier BV , S395-S396.

Metry, A., Sullivan, W., Kearns, B.C. et al. (1 more author) (2019) Would a cohort-level approach to cost-effectiveness modelling have led to a different decision in an important nice appraisal for obesity patients? In: Value in Health. ISPOR Europe 2019, 02-07 Nov 2019, Copenhagen, Denmark. Elsevier , S577-S578.